Back to search
FDAFDA · Food and drugs·Recall number D-1595-2014

COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only Distributed by Bristol Meyers Squibb Company, Princeton, NJ 08543 USA NDC 0590-0324-96

Published September 24, 2014 · Recall initiated: May 12, 2014

Summary

FDA records drug Class I recall D-1595-2014, published September 24, 2014 and initiated May 12, 2014. Recalling firm: Bristol-Meyers Squibb; Status: Terminated; Reported quantity: 50,724 Vials; Lot: Lot 00201125, Exp. 09/14; 00201126 Exp.11/14; 00201127, Exp.12/14; 00201228 Exp.06/15; 00201229 Exp. 07/15; 00201230, Exp. 09/15. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Bristol-Meyers Squibb
Distributor
Nationwide, Canada
Lot
Lot 00201125, Exp. 09/14; 00201126 Exp.11/14; 00201127, Exp.12/14; 00201228 Exp.06/15; 00201229 Exp. 07/15; 00201230, Exp. 09/15
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only Distributed by Bristol Meyers Squibb Company, Princeton, NJ 08543 USA NDC 0590-0324-96 recalled?

Yes. FDA published recall D-1595-2014 on September 24, 2014. Reported hazard: Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials

What should I do if I have this product?

Voluntary: Firm initiated · Letter